Loading…
Held by 4 funds across 2 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Tatva Chintan Pharma Chem is held by 4 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹184 Cr. Among all holding funds, the manager with the highest conviction is Nippon India ELSS Tax Saver Fund (Nippon India MF), which allocates a significant 0.64% of its entire portfolio to Tatva Chintan Pharma Chem.
In terms of category distribution, ELSS (Tax Saver) funds hold the largest exposure by market value, representing 1 positions. Across different fund houses, Nippon India MF manages the largest aggregate stake, holding a combined value of ₹170 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
| # | Rank | ||||
|---|---|---|---|---|---|
| 1 | Nippon India ELSS Tax Saver FundNippon India MFELSS (Tax Saver)₹95.03 Cr | 0.64% | ₹95.03 Cr | 7.74 L | #50 of 59 |
| 2 | ICICI Prudential MNC FundICICI Pru MFSectoral / Thematic₹7.60 Cr | 0.44% | ₹7.60 Cr | 67.1K | #50 of 54 |
| 3 | ICICI Prudential Commodities FundICICI Pru MFSectoral / Thematic₹6.43 Cr | 0.16% | ₹6.43 Cr | 56.7K | #42 of 48 |
| 4 | Nippon India Small Cap FundNippon India MFSmall Cap₹74.48 Cr | 0.15% | ₹74.48 Cr | 6.06 L | #174 of 202 |
Portfolios as on: Nippon India MF Apr 2024 · ICICI Pru MF May 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).